Comparing CSF amyloid-beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status.
Eline A J WillemseBetty M TijmsBart N M van BerckelNathalie Le BastardWiesje M van der FlierPhilip ScheltensCharlotte E TeunissenPublished in: Alzheimer's & dementia (Amsterdam, Netherlands) (2021)
Biomarker ratios p-tau/Aβ1- 42, Aβ1- 42/Aβ1- 40, t-tau/Aβ1- 42 on two automated platforms show similar optimal concordance with amyloid PET in a memory clinic cohort.